GW&K Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-99,697
Closed -$3.24M 393
2020
Q3
$3.24M Sell
99,697
-4,900
-5% -$147K 0.04% 268
2020
Q2
$2.76M Buy
104,597
+7,100
+7% +$186K 0.04% 268
2020
Q1
$2.43M Sell
97,497
-20,920
-18% -$646K 0.04% 255
2019
Q4
$4.26M Sell
118,417
-7,592
-6% -$262K 0.06% 259
2019
Q3
$4.31M Sell
126,009
-7,453
-6% -$238K 0.06% 253
2019
Q2
$3.73M Buy
+133,462
New +$3.71M 0.06% 262

Other funds holding LMAT

GW&K Investment Management's LMAT Position: Q4 2020 in Review

GW&K Investment Management sold out of LeMaitre Vascular (LMAT) in Q4 2020, closing a stake of 99,697 shares — an estimated $3.24M sold.

GW&K Investment Management first reported a position in LMAT in Q2 2019 and held it in 6 quarters. The position peaked at $4.31M in Q3 2019. 179 funds tracked by Wall St. Rank hold LMAT as of Q4 2020.

  • GW&K Investment Management reported no remaining LeMaitre Vascular position as of Q4 2020 after selling out during the quarter.
  • GW&K Investment Management sold 99,697 LeMaitre Vascular shares in Q4 2020, an estimated $3.24M.
  • GW&K Investment Management first reported a position in LeMaitre Vascular in Q2 2019 and held it in 6 quarters.
  • GW&K Investment Management's LeMaitre Vascular position peaked at $4.31M in Q3 2019.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2020.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.